Overview of transcription

magendiramanivinayag 12,322 views 74 slides Oct 01, 2016
Slide 1
Slide 1 of 74
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74

About This Presentation

Transcription - prokaryotic & Eukaryotic, transcription regulatory elements, inhibitors of Transcription


Slide Content

OVERVIEW OF TRANSCRIPTION V. Magendira Mani Assistant Professor, PG & Research Department of Biochemistry, Islamiah College (Autonomous), Vaniyambadi , Vellore District – 6357512, Tamilnadu , India. [email protected] Also available at https://tvuni.academia.edu/mvinayagam

Transcription Transcription is the first step of gene expression, in which a particular segment of DNA is copied into RNA by the enzyme RNA polymerase. Both RNA and DNA are nucleic acids, which use base pairs of nucleotides as a complementary language . The two can be converted back and forth from DNA to RNA by the action of the correct enzymes. During transcription, a DNA sequence is read by an RNA polymerase, which produces a complementary, antiparallel RNA strand called a primary transcript.

Transcription proceeds in the following general steps : 1 . One or more sigma factor protein binds to the RNA polymerase holoenzyme , allowing it to bind to promoter DNA. 2. RNA polymerase creates a transcription bubble, which separates the two strands of the DNA helix. This is done by breaking the hydrogen bonds between complementary DNA nucleotides . 3. RNA polymerase adds matching RNA nucleotides to the complementary nucleotides of one DNA strand. 4. RNA sugar-phosphate backbone forms with assistance from RNA polymerase to form an RNA strand. 5. Hydrogen bonds of the untwisted RNA-DNA helix break, freeing the newly synthesized RNA strand.

6. If the cell has a nucleus, the RNA may be further processed. This may include polyadenylation , capping, and splicing. 7. The RNA may remain in the nucleus or exit to the cytoplasm through the nuclear pore complex. The stretch of DNA transcribed into an RNA molecule is called a transcription unit and encodes at least one gene. If the gene transcribed encodes a protein, messenger RNA (mRNA) will be transcribed; the mRNA will in turn serve as a template for the protein synthesis through translation. Alternatively, the transcribed gene may encode for either non-coding RNA (such as micro RNA), ribosomal RNA ( rRNA ), transfer RNA ( tRNA ), or other ribozymes. Overall, RNA helps synthesize, regulate, and process proteins; it therefore plays fundamental role in performing functions within a cell.

Regulation of transcription A gene consists of a transcriptional region and a regulatory region. The transcriptional region is the part of DNA to be transcribed into a primary transcript (an RNA molecule complementary to the transcriptional region). The regulatory region can be divided into cis -regulatory (or cis -acting) elements and trans-regulatory (or trans-acting) elements. The cis -regulatory elements are the binding sites of transcription factors which are the proteins that, upon binding with cis -regulatory elements, can affect (either enhance or repress) transcription. The trans-regulatory elements are the DNA sequences that encode transcription factors.

Transcription factor In molecular biology and genetics, a transcription factor (sequence-specific DNA-binding factor) is a protein that binds to specific DNA sequences, thereby controlling the rate of transcription of genetic information from DNA to messenger RNA. Transcription factors perform this function alone or with other proteins in a complex, by promoting (as an activator), or blocking (as a repressor ) the recruitment of RNA polymerase (the enzyme that performs the transcription of genetic information from DNA to RNA) to specific genes .

Activators Activators enhance the interaction between RNA polymerase and a particular promoter, encouraging the expression of the gene. Activators do this by increasing the attraction of RNA polymerase for the promoter, through interactions with subunits of the RNA polymerase or indirectly by changing the structure of the DNA. Repressors Repressors bind to non-coding sequences on the DNA strand that are close to or overlapping the promoter region, inhibiting RNA polymerase's progress along the strand, thus blocking the expression of the gene.

Enhancer In genetics, an enhancer is a short (50-1500 bp ) region of DNA that can be bound with proteins (activators ) to activate transcription of a gene or genes. These proteins are usually referred to as transcription factors. Enhancers are generally cis -acting, located up to 1 Mbp away from the gene. There are hundreds of thousands of enhancers in the human genome. Enhancers are sites on the DNA helix that are bound to by activators in order to loop the DNA bringing a specific promoter to the initiation complex.

Silencers Silencers are regions of DNA that are bound by transcription factors in order to silence gene expression. The mechanism is very similar to that of enhancers. In genetics, a silencer is a DNA sequence capable of binding transcription regulation factors, called repressors. DNA contains genes and provides the template to produce messenger RNA (mRNA ). That mRNA is then translated into proteins that activate or inactivate gene expression in cells. When a repressor protein binds to the silencer region of DNA, RNA polymerase—the enzyme that transcribes DNA into RNA—is prevented from binding to the promoter region. With the transcription of DNA into RNA blocked, the translation of RNA into proteins is impossible . Thus, silencers prevent genes from being expressed as proteins .

Specificity factors alter the specificity of RNA polymerase for a given promoter or set of promoters, making it more or less likely to bind to them (i.e. sigma factors used in prokaryotic transcription). A sigma factor (σ factor) is a protein needed only for initiation of RNA synthesis. It is a bacterial transcription initiation factor that enables specific binding of RNA polymerase to gene promoters. The specific sigma factor used to initiate transcription of a given gene will vary, depending on the gene and on the environmental signals needed to initiate transcription of that gene.

Promoter In genetics, a promoter is a region of DNA that initiates transcription of a particular gene. Promoters are located near the transcription start sites of genes, on the same strand and upstream on the DNA (towards the 5' region of the sense strand). Promoters can be about 100–1000 base pairs long. A core enzyme consists of the subunits of an enzyme that are needed for catalytic activity, as in the core enzyme RNA polymerase. RNA polymerase is a core enzyme consisting of five subunits: 2 α subunits, 1 β subunit, 1 β‘ subunit, and 1 ω subunit. At the start of initiation, the core enzyme is associated with a sigma factor that aids in finding the appropriate -35 and -10 base pairs downstream of promoter sequences. When the sigma factor and RNA polymerase combine, they form a holoenzyme .

Inducers In molecular biology, an inducer is a molecule that starts gene expression. An inducer can bind to repressors or activators. Inducers function by disabling repressors. The gene is expressed because an inducer binds to the repressor . The binding of the inducer to the repressor prevents the repressor from binding to the operator . RNA polymerase can then begin to transcribe operon genes .

Transcriptional repressors Transcriptional repressors are proteins that bind to specific sites on DNA and prevent transcription of nearby genes. (RNA can also inhibit transcription, but inhibitory RNAs are not usually called repressors). In molecular genetics, a repressor is a DNA- or RNA-binding protein that inhibits the expression of one or more genes by binding to the operator. A DNA-binding repressor blocks the attachment of RNA polymerase to the promoter, thus preventing transcription of the genes into messenger RNA. An RNA-binding repressor binds to the mRNA and prevents translation of the mRNA into protein. This blocking of expression is called repression. A defining feature of transcription factors is that they contain one or more DNA binding domains (DBDs), which attach to specific sequences of DNA adjacent to the genes that they regulate.

transcription – the process of making RNA from a DNA template by RNA polymerase factor – a substance, such as a protein, that contributes to the cause of a specific biochemical reaction or bodily process transcriptional regulation – controlling the rate of gene transcription for example by helping or hindering RNA polymerase binding to DNA upregulation , activation, or promotion – increase the rate of gene transcription downregulation , repression, or suppression – decrease the rate of gene transcription coactivator – a protein that works with transcription factors to increase the rate of gene transcription corepressor – a protein that works with transcription factors to decrease the rate of gene transcription

PROKARYOTIC TRANSCRIPTION

PROKARYOTIC TRANSCRIPTION   Transcription  is the first step of  gene expression , in which a particular segment of  DNA  is copied into  RNA  ( mRNA ) by the  enzyme   RNA polymerase . Simply stated transcription is the synthesis of RNA from a DNA template or The flow of genetic information from DNA to RNA or synthesis single stranded RNA from double stranded DNA. All the three RNAs- tRNA , mRNA, rRNA are synthesized form the DNA by DNA dependent RNA polymerase.

RNA POLYMERASE The E.Coli RNA polymerase is one of the largest enzyme in the cell. The enzyme consist of five subunits. These are alpha α, beta β, beta prime β', omega and sigma. Two alpha subunits: Essential for assembly of the enzyme activation by some regulatory proteins These two identical alpha subunit play role in promotor recognition Βeta subunit It is the catalytic centre of RNA polymerase and has two domains responsible for transcription initation and elongation. Beta subunit binds the nucleotide triphosphate (NTP) subtrates and interacts with sigma .

Βeta prime subunit Larghest subunit functions in DNA binding, this subunit binds two Zn 2+ ions which are thought to participate in the catalytic function of the polymerase.  Sigma subunit The most common sigma factor in E.Coli of sigma -70 (molecular mass 70kDa). Binding of sigma factor converts the core enzyme into RNA polymerase holo enzyme. Sigma factor critical role in promotor recognition, but it is not required for elongation.

The sigma factor contributes to promotor recognition by decreasing the affinity of the core enzymes for non specific DNA sites and increasing the affinity for the promotor . Like DNA polymerase RNA polymerase links ribonucleotide 5’ triphosphates (ATP,GTP,CTP,UTP) in an order specified by base pairing with a template. The ribonucleotides are linked through 3’ – 5’ phosphor diester bond formed by the attach of 5’ alpha phosphate of one ribonucleotide to the 3’ OH group of adjacent ribonucleotide . The enzyme RNA polymerase moves along a DNA template strand in the 3’-5’ direction joining the 5’ phosphate of an incoming ribonucleotide to the 3’-OH of the previous residue. Thus the RNA chain grows 5’- 3’ during transcription. The reaction is driven by subsequent hydrolysis of PPi to inorganic phosphate by ubiquitoes pyrophosphate activity.

Three steps in transcription Initiation Elongation Termination Initiation  Initiation begins with the sigma subunit of RNA polymerase recognizes the promotor sequence, and binding of DNA dependent RNA polymerase holoenzyme to promoter in template of DNA forms closed promotor complex.  In genetics, a promoter is a region of DNA that initiates transcription of a particular gene. Promoters are located near the transcription start sites of genes, on the same strand and upstream on the DNA (towards the 5' region of the sense strand). Promoters can be about 100–1000 base pairs long 

 Once the closed promotor complex is established, the RNA ploymerase holo enzyme unwinds about 14 base pairs of DNA (base pair located at –10 to + 2 relative to the transcription start site) forming a very stable open promotor complex. In this comples RNA polymerase holo enzyme bound very tightly to the DNA.  The -35 region and the -10 (" Pribnow box") region comprise the core prokaryotic promoter, and |T| stands for the terminator. The DNA on the template strand between the +1 site and the terminator is transcribed into RNA, which is then translated into protein. At this stage, the DNA is double-stranded ("closed"). This holoenzyme /wound-DNA structure is referred to as the closed complex.

 -10 sequence/ Pribnow box/TATA box/ Hogness box – it contain six nucleotide (TATAAT) located 8 to 10 nucleotide to the left of transcriptional start site. The – 10 region important for DNA unwinding.  35 region - it contain six nucleotide (TTGACA), this sequence is separated from -10 box by 19 bp.

In order to transcription to begin, the DNA duplex must be “opened” so that RNA polymerase has assess to single stranded template. The RNAP sigma subunit is directly involved in melting the DS-DNA . Interaction of the sigma subunit with the non template strand maintains the open complex. Human as 105 initiation sites. RNAP first scans DNA at 10 -3 bp /s until it finds (specially sigma factor) promoter sequences to which it binds firmly. Promoters are present in coding strand in 5’ to 3’ direction.    

Elongation Once the promoters region has been recognized by sigma factor of holoenzyme the enzyme begins to synthesis RNA sequence, sigma factor is released. This enzyme has no exo / endo nuclease activity and cannot repair the mistakes as DNA polymerase in replication. RNA polymerase add complementary base to the template strand of DNA. It adds Thiamine for Adenine (T =A), Guanine for Cytosine (G ≡ C), Cytosine for Guanine (C ≡ G) and Adenine for Uracil (A = U). Most transcripts originate using adenosine-5'-triphosphate (ATP) and, to a lesser extent, guanosine-5'-triphosphate (GTP) (purine nucleoside triphosphates) at the +1 site. Uridine-5'-triphosphate (UTP) and cytidine-5'-triphosphate (CTP) (pyrimidine nucleoside triphosphates) are disfavoured at the initiation site .

The dissociation of σ allows the core RNA polymerase enzyme to proceed along the DNA template, synthesizing mRNA in the 5' to 3' direction at a rate of approximately 40 nucleotides per second. As elongation proceeds, the DNA is continuously unwound ahead of the core enzyme and rewound behind it . Since the base pairing between DNA and RNA is not stable enough to maintain the stability of the mRNA synthesis components, RNA polymerase acts as a stable linker between the DNA template and the nascent RNA strands to ensure that elongation is not interrupted prematurely.  

TERMINATION E. coli has 2 class of termination sequence in template DNA. One class is recognized by termination protein "Rho" ,that's rho-dependent and other is rho independent. a. Rho-independent. Formation of RNA transcript with pallindromic sequence (self complementary) that form hairpin structure (GC rich) and another structure is conserved string of 3A residue in 3’ end of template strand.

b. Rho-dependent: Rho protein associates with RNA at C-rich site near 3’ end and moves along the RNA until it reaches RNAP paused at termination site. The rho protein has ATP dependent RNA-DNA helicase activity that promotes release of RNA-DNA hybrid helix causing the release of RNA. In eukaryotic cell after 3’ end of transcript is encoded, RNA endonuclease cleaves the primary transcript about 15 bases 3’ to consensus sequence AAUAAA that serves as cleavage signal.

Action of antibiotics:  Rifampin (anti tuberculosis drug) - inhibits the initiation of transcription by binding to the β subunit of prokaryotic RNA polymerase, thus interfering with the formation of the first phosphodiester bond.  Dactinomycin ( Actinomycin D) – Anti cancer drug - It binds to the DNA template and interferes with the movement of RNA polymerase along the DNA Inhibitors

EUKARYOTIC TRANSCRIPTION

EUKARYOTIC TRANSCRIPTION Eukaryotic transcription is the elaborate process that eukaryotic cells use to copy genetic information stored in DNA into units of RNA replica. A eukaryotic cell has a nucleus that separates the processes of transcription and translation. Eukaryotic transcription occurs within the nucleus, where DNA is packaged into nucleosomes and higher order chromatin structures. The complexity of the eukaryotic genome requires a great variety and complexity of gene expression control. Eukaryotic transcription proceeds in three sequential stages: initiation, elongation, and termination. The transcriptional machinery that catalyzes this complex reaction has at its core three multi-subunit RNA polymerases.

Eukaryotes have three nuclear RNA polymerases, each with distinct roles and properties RNA polymerase I RNA polymerase I (Pol I) catalyzes the transcription of all rRNA genes except 5S rRNA . These rRNA genes are organized into a single transcriptional unit and are transcribed into a continuous transcript. This precursor is then processed into three rRNAs : 18S, 5.8S, and 28S. The transcription of rRNA genes takes place in a specialized structure of the nucleus called the nucleolus, where the transcribed rRNAs are combined with proteins to form ribosomes.

Promoter Structure: For RNA pol-I:  Genes for ribosomal RNA are exclusively transcribed by RNA polymerase-I.  In eukaryotic system most active and highly productive genes, which are transcribed most of the time, are ribosomal RNA genes.  More than 90 % of the total RNA found in any eukaryotic cell is rRNA .  Its synthesis is triggered, when cells are activated for cell proliferation, in such situations tremendous increase of rRNA takes place, ex. rRNA synthesis during oogenesis is a par excellent example.

Initiation  It has, what is termed as core promoter region between (-) 10 and (-) 45 and an upstream control elements (UCE), it is the region to which upstream element binding factors bind.  The core region attracts selectivity factor SL-I, 3 TAFs (TBP associated factors) and TBP (TATA binding factors). Positioning of the TBP is assisted and determined by the SL-I and then TAFs bring TBP.  It is now known that two histone like proteins are also associated with this complex.  This assembly ultimately brings RNA pol-I to the site. But the activation depends on upstream control element binding factors UBF 1; they bind not only to the core but also to UCE.  UBFI binding results in protein-protein interaction in such a way two units of UBFs join with one another with a DNA loop, and activate the RNA pol-I complex.

Elongation As Pol I escapes and clears the promoter, UBF and SL1 remain-promoter bound, ready to recruit another Pol I. Indeed, each active rDNA gene can be transcribed multiple times simultaneously. Pol I does seem to transcribe through nucleosomes, either bypassing or disrupting them, perhaps assisted by chromatin-remodeling activities. In addition, UBF might also act as positive feedback, enhancing Pol I elongation through an anti-repressor function. An additional factor, TIF-IC, can also stimulate the overall rate of transcription and suppress pausing of Pol I. As Pol I proceeds along the rDNA , supercoils form both ahead and behind the complex. These are unwound by topoisomerase I or II at regular interval, similar to what is seen in Pol II-mediated transcription. Elongation is likely to be interrupted at sites of DNA damage. Transcription-coupled repair occurs similarly to Pol II-transcribed genes and require the presence of several DNA repair proteins, such as TFIIH, CSB, and XPG.

Termination In higher eukaryotes, TTF-I binds and bends the termination site at the 3' end of the transcribed region. This will force Pol I to pause. TTF-I, with the help of transcript-release factor PTRF and a T-rich region, will induce Pol I into terminating transcription and dissociating from the DNA and the new transcript. Evidence suggests that termination might be rate-limiting in cases of high rRNA production. TTF-I and PTRF will then indirectly stimulate the reinitiation of transcription by Pol I at the same rDNA gene. In organisms such as budding yeast the process seems to be much more complicated.

rRNA Synthesis and Processing The genes coding for rRNA (except 5S rRNA ) are located in the nucleolar part of the nucleus. The rRNA genes are highly repetitious and mammalian cells contain 100 to 2000 copies of the rRNA genes per cell. The genes are organised in transcription units separated by non-transcribed spacers. Each transcription unit contains sequences coding for 18S, 5.8S and 28S rRNA . The transcription units are transcribed by RNA polymerase I into giant RNA molecules, primary transcripts, that in addition to the sequences corresponding to 18S, 5.8S and 28S rRNA contains external and internal transcribed spacer sequences. The rate of nucleolar transcription is very high and many polymerases operate on the same transcription unit. The transciptionally active DNA therefore has a Christmas tree-like appearance on electron microscopic pictures.

The primary transcript is processed into the mature 18S, 5.8S and 28S rRNAs . The processing involves exo - and endo-nucleolytic cleavages guided by snoRNA (small nucleolar RNAs) in complex with proteins. The mature rRNAs contain modified nucleotides which are added after transcription by a snoRNA -dependent mechanism. 5S ribosomal RNA is transcribed by RNA polymerase III in the nucleoplasm. Each eukaryotic cell contains a high number of copies of the 5S coding gene (up to 20 000 copies per cell). 5S rRNA contains overlapping binding sites for two different proteins, ribosomal protein L5 and transcription factor TFIIIA. The mutual exclusive binding of these two proteins to 5S rRNA is important for coordinating the expression of 5S rRNA to the production of the other rRNAs .

RNA polymerase II RNA polymerase II  RNA polymerase II (RNAP II and Pol II) is an enzyme found in eukaryotic cells. It catalyzes the transcription of DNA to synthesize precursors of mRNA and most snRNAs , siRNAs , and all miRNAs and microRNA. A 550 kDa complex of 12 subunits, RNAP II is the most studied type of RNA polymerase. A wide range of transcription factors are required for it to bind to upstream gene promoters and begin transcription.  Many Pol II transcripts exist transiently as single strand precursor RNAs (pre-RNAs) that are further processed to generate mature RNAs. For example, precursor mRNAs (pre-mRNAs) are extensively processed before exiting into the cytoplasm through the nuclear pore for protein translation.

Promoter RNA polymerase – II Most eukaryotes use TATA box (it's a little further away from initiation start area). In eukaryotes, the promoters are a little more complex, these elements functionally analogous to the -10 and -35 in prokaryotes, they orient polymerase and bind proteins.

Initiation To begin transcription, eucaryotic RNA polymerase II requires the general transcription factors. These transcription factors are called TFIIA, TFIIB, and so on. (A) The promoter contains a DNA sequence called the TATA box, which is located 25 nucleotides away from the site where transcription is initiated. (B) The TATA box is recognized and bound by transcription factor TFIID, which then enables the adjacent binding of TFIIB. (C) For simplicity the DNA distortion produced by the binding of TFIID is not shown. (D) The rest of the general transcription factors as well as the RNA polymerase itself assemble at the promoter. (E) TFIIH uses ATP to pry apart the double helix at the transcription start point, allowing transcription to begin. TFIIH also phosphorylates RNA polymerase II, releasing it from the general factors so it can begin the elongation phase of transcription. As shown, the site of phosphorylation is a long polypeptide tail that extends from the polymerase molecule.

Processing of mRNA All the primary transcripts produced in the nucleus must undergo processing steps to produce functional RNA molecules for export to the cytosol. We shall confine ourselves to a view of the steps as they occur in the processing of pre-mRNA to mRNA. The steps: • Synthesis of the cap. This is a stretch of three modified nucleotides attached to the 5' end of the pre-mRNA. • Synthesis of the poly (A) tail. This is a stretch of adenine nucleotides attached to the 3' end of the pre-mRNA. • Step-by-step removal of introns present in the pre-mRNA and splicing of the remaining exons. This step is required because most eukaryotic genes are split.

5' cap addition • A 5' cap (also termed an RNA cap, an RNA 7-methylguanosine cap, or an RNA m7G cap) is a modified guanine nucleotide that has been added to the "front" or 5' end of a eukaryotic messenger RNA shortly after the start of transcription. The 5' cap consists of a terminal 6-methylguanosine residue that is linked through a 5'-5'-triphosphate bond to the first transcribed nucleotide. Its presence is critical for recognition by the ribosome and protection from RNases . • Shortly after the start of transcription, the 5' end of the mRNA being synthesized is bound by a cap-synthesizing complex associated with RNA polymerase. This enzymatic complex catalyzes the chemical reactions that are required for mRNA capping. Synthesis proceeds as a multi-step biochemical reaction.

Splicing Splicing is the process by which pre-mRNA is modified to remove certain stretches of non-coding sequences called introns; the stretches that remain include protein-coding sequences and are called exons. Sometimes pre-mRNA messages may be spliced in several different ways, allowing a single gene to encode multiple proteins. This process is called alternative splicing. Splicing is usually performed by an RNA-protein complex called the spliceosome , but some RNA molecules are also capable of catalyzing their own splicing.

Editing Polyadenylation Polyadenylation is the covalent linkage of a polyadenylyl moiety to a messenger RNA molecule. In eukaryotic organisms, with the exception of histones, all messenger RNA (mRNA) molecules are polyadenylated at the 3' end. The poly (A) tail and the protein bound to it aid in protecting mRNA from degradation by exonucleases . Polyadenylation is also important for transcription termination, export of the mRNA from the nucleus, and translation. mRNA can also be polyadenylated in prokaryotic organisms, where poly(A) tails act to facilitate, rather than impede, exonucleolytic degradation.

Polyadenylation occurs during and immediately after transcription of DNA into RNA. After transcription has been terminated, the mRNA chain is cleaved through the action of an endonuclease complex associated with RNA polymerase. After the mRNA has been cleaved, around 250 adenosine residues are added to the free 3' end at the cleavage site. This reaction is catalyzed by polyadenylate polymerase. Just as in alternative splicing, there can be more than one polyadenylation variant of an mRNA. Polyadenylation site mutations also occur. The primary RNA transcript of a gene is cleaved at the poly-A addition site, and 100-200 A’s are added to the 3’ end of the RNA. If this site is altered, an abnormally long and unstable mRNA results. Several beta globin mutations alter this site: one example is AATAAA -> AACAAA. Moderate anemia was result.

RNA polymerase III RNA polymerase III RNA polymerase III (Pol III) transcribes small non-coding RNAs, including tRNAs , 5S rRNA , U6 snRNA , SRP RNA, and other stable short RNAs such as ribonuclease P RNA. Structure of eukaryotic RNA polymerase  RNA Polymerases I, II, and III contain 14, 12, and 17 subunits, respectively.  All three eukaryotic polymerases have five core subunits that exhibit homology with the β, β’, α I, α II, and ω subunits of E. coli RNA polymerase.  An identical ω- like subunit (RBP6) is used by all three eukaryotic polymerases, while the same α- like subunits are used by Pol I and III.

The three eukaryotic polymerases share four other common subunits among themselves. The remaining subunits are unique to each RNA polymerase. The additional subunits found in Pol I and Pol III relative to Pol II, are homologous to Pol II transcription factors.  Crystal structures of RNA polymerases I and II provide an opportunity to understand the interactions among the subunits and the molecular mechanism of eukaryotic transcription in atomic detail.

Promoter for RNA polymerase – III  RNA pol-III transcribes small molecular weight RNAs such as tRNAs , 5sRNAs, 7sKRNAs, 7sLRNAs, U6sn RNAs, some ncRNAs and it also transcribes some ADV, EBV and many eukaryotic viral genes.  The 5s rRNA and tRNA genes have promoters within the coding region of the gene.  The promoter regions for 7S and U6sn RNAs, more or less, look like RNA pol-II promoters, with little differences.  Though the size of the genes is small ranging from 160 to 400 bp , their promoters are well defined for transcriptional initiation from their respective Start sites in the promoters.

Initiation Initiation: the construction of the polymerase complex on the promoter. Pol III is unusual (compared to Pol II) requiring no control sequences upstream of the gene, instead normally relying on internal control sequences - sequences within the transcribed section of the gene (although upstream sequences are occasionally seen, e.g. U6 snRNA gene has an upstream TATA box as seen in Pol II Promoters). Class I  Typical stages in 5S rRNA (also termed class I) gene initiation:  TFIIIA (Transcription Factor for polymerase III A) binds to the intragenic (lying within the transcribed DNA sequence) 5S rRNA control sequence, the C Block (also termed box C).

 TFIIIA Serves as a platform that replaces the A and B Blocks for positioning TFIIIC in an orientation with respect to the start site of transcription that is equivalent to what is observed for tRNA genes.  Once TFIIIC is bound to the TFIIIA-DNA complex the assembly of TFIIIB proceeds as described for tRNA transcription. Class II  Typical stages in a tRNA (also termed class II) gene initiation:  TFIIIC (Transcription Factor for polymerase III C) binds to two intragenic (lying within the transcribed DNA sequence) control sequences, the A and B Blocks (also termed box A and box B).

 TFIIIC acts as an assembly factor that positions TFIIIB to bind to DNA at a site centered approximately 26 base pairs upstream of the start site of transcription. TFIIIB (Transcription Factor for polymerase III B), consists of three subunits: TBP (TATA Binding Protein), the Pol II transcription factor TFIIB-related protein, Brf1 (or Brf2 for transcription of a subset of Pol III-transcribed genes in vertebrates) and Bdp1.  TFIIIB is the transcription factor that assembles Pol III at the start site of transcription. Once TFIIIB is bound to DNA, TFIIIC is no longer required. TFIIIB also plays an essential role in promoter opening.  TFIIIB remains bound to DNA following initiation of transcription by Pol III (unlike bacterial σ factors and most of the basal transcription factors for Pol II transcription). This leads to a high rate of transcriptional reinitiation of Pol III-transcribed genes.

Class III  Typical stages in a U6 snRNA (also termed class III) gene initiation (documented in vertebrates only):  SNAPc (SNRNA Activating Protein complex) (also termed PBP and PTF) binds to the PSE (Proximal Sequence Element) centered approximately 55 base pairs upstream of the start site of transcription. This assembly is greatly stimulated by the Pol II transcription factors Oct1 and STAF that bind to an enhancer-like DSE (Distal Sequence Element) at least 200 base pairs upstream of the start site of transcription. These factors and promoter elements are shared between Pol II and Pol III transcription of snRNA genes.

 SNAPc acts to assemble TFIIIB at a TATA box centered 26 base pairs upstream of the start site of transcription. It is the presence of a TATA box that specifies that the snRNA gene is transcribed by Pol III rather than Pol II.  The TFIIIB for U6 snRNA transcription contains a smaller Brf1 paralogue , Brf2.  TFIIIB is the transcription factor that assembles Pol III at the start site of transcription. Sequence conservation predicts that TFIIIB containing Brf2 also plays a role in promoter opening.  Each of the internal sequence represents certain tRNA domains, such as; A block representing D-arm and B block representing TUCG loop respectively. .

 At the time of transcriptional initiation, a transcriptional factor TF-C made up of six subunits recognizes the sequence boxes and binds to them and positions the proteins in such a way one end of the protein is found at the start site.  Then this protein guides the TF-B, which is made up of several subunits, to be positioned at start site.  Then the RNA pol-III recognizes these proteins and binds to them and binds tightly and initiates transcription at the pre defined site.  Here the role of a promoter is to provide recognition sequence modules for specific proteins to assemble in such a way; the polymerase is properly positioned to initiate transcription exactly at a pre-defined nucleotide, which is called start site.

 If sequence motifs are not present, protein fails to bind and RNA pol fails to associate with accessory proteins and initiate transcription at specific site.  In these promoters there is sequence such as TATA box for the binding of TBP, which acts as the positional factor.  This is what the promoter is and what it is meant for; this is why promoter is required. 5sRNA genes:  Ribosomal RNAs, in eukaryotes consist of 28s, 18s, 5.8s and 5s RNAs.  The 28s, 18s and 5.8s rRNAs are synthesized as one block from nucleolar organizer region of the DNA, and the precursor 45S, larger than the final RNAs, is processed into 28s, 18s, and 5.8s RNAs, but no 5s RNA segment.

 Gene for 5s RNA are located elsewhere in the chromosomes, many times they are found just behind telomeres.  The number of 5s RNA genes in a haploid genome can vary from 200 to more than 1200, and all of them are tandemly repeated in the cluster and each of them are separated by non transcribing spacer.  During transcriptional initiation, TF III A first recognizes the C box and binds, then TF-III-B containing TBP binds to the promoter using TF-III A and it positions at start site.  Then the RNA-pol-III complex assembles at the start region and initiates transcription at the predefined site.

 Again the role of internal promoters is to position the transcriptional factors and ultimately the RNA-pol so as to initiate at specified site.  5s RNA expression differs in Oocyte and somatic tissues.  Transcription factor TF III A, 40 KD proteins is produced in Oocyte specific manner.  This protein binding to internal site of the 5s gene activates the gene expression by facilitating the assembly of TF III-C and B and finally RNA pol-III.  At a late stage of oogenesis, enormous quantities of 5sRNAs are produced, and the TF-III A binds to 5s RNA, thus all TF III-As get consumed and none of the factors are available for the activation of Oocyte specific 5sRNA gene. Termination Polymerase III terminates transcription at small polyTs stretch. In Eukaryotes, a hairpin loop is not required, as it is in prokaryotes

Processing tRNA Synthesis & Processing 1. tRNA is transcribed by RNA polymerase III. The transcription product, the pre- tRNA , contains additional RNA sequences at both the 5’ and 3’-ends. These additional sequences are removed from the transcript during processing. The additional nucleotides at the 5’-end are removed by an unusual RNA containing enzyme called ribonuclease P ( RNase P). 2. Some tRNA precursors contain an intron located in the anticodon arm. These introns are spliced out during processing of the tRNA .

3. All mature tRNAs contain the trinucleotide CCA at their 3’-end. These three bases are not coded for by the tRNA gene. Instead, these nucleotides are added during processing of the pre- tRNA transcript. The enzyme responsible for the addition of the CCA-end is tRNA nucleotidyl transferase and the reaction proceeds according to the following scheme: tRNA +CTP --> tRNA -C + PPi (pyrophosphate) tRNA -C +CTP --> tRNA -C-C + PPi tRNA -C-C +ATP --> tRNA -C-C-A + PPi 4. Mature tRNAs can contain up to 10% bases other than the usual adenine (A), guanine (G), cytidine (C) and uracil (U). These base modifications are introduced into the tRNA at the final processing step. The biological function of most of the modified bases is uncertain and the translation process seems normal in mutants lacking the enzymes responsible for modifying the bases.

α- Amanitin and actinomycin D are commonly used inhibitors of transcription. α- Amanitin binds to the largest subunits of RNA polymerase II (RNAP II ) and RNAP III, with RNAP II being the most sensitive. As a consequence, the incorporation of new ribonucleotides into the nascent RNA chains is blocked Rifamycins , macrocyclic antibiotics produced by Streptomyces mediterranei , inhibit the bacterial RNA polymerase, by binding to the beta subunit, which is one of the five subunits of the enzyme: They have little action on the human RNA polymerase. This group of antibiotics includes rifampicin, rifabutin and rifamycine SV. INHIBITORS OF TRANSCRIPTION

Rifampin Rifampin , also called rifampicin, has a bactericidal activity against a wide range of microorganisms, of which Mycobacterium tuberculosis and Mycobacterium lepræ as well as staphylococci, streptococci, Neisseria, Listeria monocytogenes , Brucella … It is used as antituberculous drug, always combined to two or three other drugs to avoid the emergence of resistance and as anti-leprous drug. Its other clinical uses are brucellosis and the prophylaxis of meningococcal meningitis . Rifampicin ( Rifadin *, Rimactan *) is marketed alone and in combination with isoniazid ( Rifinah *) and with isoniazid and pyrazinamid ( Rifater *).

Rifabutin Rifabutin has an antibacterial activity quite similar to that of rifampin, it is active against mycobacteria such as Mycobacterium tuberculosis and Mycobacterium avium complex. It is also active against several gram-positive bacteria. Rifabutin ( Mycobutin *) is used for the curative treatment of multidrug-resistant tuberculosis and for the prophylactic treatment of Mycobacterium avium complex infection in immunocompromised patients. Rifabutin is a less potent microsomal enzyme inducer than rifampin and can be preferred in patients taking other drugs. Rifampin and rifabutin can elicit a rise in hepatic transaminases and thrombocytopenia and neutropenia. They give an orange color to the urine. Rifabutin can cause uveitis .

Rifamycine Rifamycine S.V is used in the form of ophthalmic solution. Rifapentine Rifapentine is a rifampin analog used in certain countries for tuberculosis therapy.

V. Magendira Mani Assistant Professor, PG & Research Department of Biochemistry, Islamiah College (Autonomous), Vaniyambadi , Vellore District – 6357512, Tamilnadu , India. [email protected] ; vinayagam [email protected] https://tvuni.academia.edu/mvinayagam